跳至主要内容
临床试验/NCT02997553
NCT02997553已完成3 期

Reliability of Indocyanine Green Use in Sentinel Lymph Node Identification in Cancer Surgery

Institut de Cancérologie de Lorraine2 个研究点 分布在 1 个国家目标入组 744 人开始时间: 2017年11月29日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
744
试验地点
2
主要终点
Non-inferiority of indocyanine green guided sentinel lymph node biopsy

研究概览

简要总结

This is a single-center prospective clinical trial to evaluate non-inferiority of indocyanine green guided sentinel lymph node biopsy compared with the gold standard Technecium99 guided sentinel lymph node biopsy in patients with cancers and subjected to surgery.

The diagnostic performance and the tolerance of indocyanine green (ICG) to the radio-isotope (Techniciun99) in the detection of sentinel lymph nodes will be assess using an "Optonuclear" probe (EURORAD S.A.) and QUEST camera

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age >18 years
  • cancer histologically proved
  • patient eligible for sentinel node detection
  • contraceptive methods for men and women of childbearing age
  • signed informed consent form
  • patient affiliated to the social security system

排除标准

  • neoadjuvant chemotherapy or hormone therapy
  • adenopathy (s) clinically suspicious or positively cytopenic
  • women who are pregnant or breast-feeding
  • associated pathology that may prevent patient of receive indocyanine green
  • ongoing participation in another clinical trial with an investigational drug
  • patients deprived of liberty or under supervision
  • impossibility to undergo medical follow-up of the trial for geographical, social or psychological reasons

研究组 & 干预措施

sentinel lymph node detection

Experimental

Each patient receive both injections of Technetium99 (standard care) and indocyanine green.

The detection of sentinel lymph node will be conducted by an optonuclear probe able to detect the radioactive and the fluorescence signal during surgery.

干预措施: Indocyanine green (Drug)

sentinel lymph node detection

Experimental

Each patient receive both injections of Technetium99 (standard care) and indocyanine green.

The detection of sentinel lymph node will be conducted by an optonuclear probe able to detect the radioactive and the fluorescence signal during surgery.

干预措施: Optonuclear probe (Device)

sentinel lymph node detection

Experimental

Each patient receive both injections of Technetium99 (standard care) and indocyanine green.

The detection of sentinel lymph node will be conducted by an optonuclear probe able to detect the radioactive and the fluorescence signal during surgery.

干预措施: Technetium99 (Drug)

sentinel lymph node detection

Experimental

Each patient receive both injections of Technetium99 (standard care) and indocyanine green.

The detection of sentinel lymph node will be conducted by an optonuclear probe able to detect the radioactive and the fluorescence signal during surgery.

干预措施: Quest Camera (Device)

结局指标

主要结局

Non-inferiority of indocyanine green guided sentinel lymph node biopsy

时间窗: 1 day

The detection rate is defined by the number of patient who at least one sentinel node detected by fluorescence or isotope intra operatively. Per-operative detection is defined by the identification of at least one sentinel lymph node in the lymphatic drainage area.

次要结局

  • Total number of sentinel lymph node detected(1 day)
  • Number of false negative result(1 day)
  • Allergic reactions(8 days)
  • Evaluation of pain(1 day)
  • fluorescence imaging(1 day)

研究者

发起方
Institut de Cancérologie de Lorraine
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验